The PG cell wall of bacterial cells is a macromolecular polymer consisting of β-1,4-linked glycan strands that are cross-linked by short d-amino acid (DAA)-containing peptide chains. PG is an essential structure for bacterial cells that precisely determines cell size and shape, and it enables them to resist lysis. The PG biosynthetic pathway is an attractive target for antibiotic intervention, because the key polymerization and cross-linking reactions take place on the solvent-accessible surface of the bacterial cell. In addition, as animal cells do not have a PG shell, the potential for toxicity to humans is minimized 1 . Unfortunately, the resistance of pathogenic bacteria to even the newest PG-acting antibiotics (e.g., carbapenem-resistant enterobacteriaceae) has increased alarmingly, which underscores the urgent need for novel additions to our current antibiotic pharmacopeia. However, the development of novel PG-acting agents has lagged because our overall knowledge of PG biosynthesis and turnover is still very limited 2,3 . This is due, in part, to the lack of tools or methods to enable real-time spatiotemporal tracking of PG biosynthesis in live bacterial cells 4, 5 . Recently, we have shown that FDAAs enable rapid and covalent detection of cell wall biosynthesis, in real time, in live cells and in a broad range of bacterial species 6 . This method has already been used to study the growth or PG synthesis mechanisms in various bacterial species [7] [8] [9] [10] .
its application is limited to E. coli, and it also suffers from poor substrate analog utilization. More recently, we have shown that d-alanyl-d-alanine dipeptide analogs with small bio-orthogonal handles can efficiently and stably label PGs of a diverse set of bacteria through a similar cytoplasmic incorporation route 18 . Unfortunately, the detection of the incorporated material requires fixed and permeabilized samples, and therefore this method cannot be used to trace the growth of live bacteria.
Other efforts have used covalent incorporation of d-cysteine into PGs, either through chemoenzymatic incorporation into the Park nucleotide 19 or through live cell incorporation of d-cysteine into the stem peptide via a periplasmic exchange mechanism 12, 13, [17] [18] [19] [20] . In this approach, once incorporated into the PG, the nucleophilic thiol group of d-cysteine can be used to capture an electrophilic reporter group (e.g., pyrene or biotin) and enable direct or indirect (via antibody capture) fluorescence detection. Although this method has been successfully used to label the bacterial cell wall and to monitor PG synthesis in diverse Gram-negative bacteria 13, 21 , it requires the laborious purification of PG sacculi away from cellular proteins, which contain reactive thiol groups. This requirement not only limits the signal detection to hollow sacculi but also precludes the application of this method for real-time detection of PG synthesis. Despite its limitations, d-cysteine labeling of PGs suggested that a similar approach using FDAAs might be generally applicable to bacteria, as evolutionary distinct species are known to produce and incorporate various DAAs into their PGs 22, 23 .
Development of FDAAs
Our design strategy was built on the aforementioned tolerance of diverse bacterial species to incorporation of various DAAs, including the relatively small d-cysteine and the largest natural DAA, d-tryptophan, into their PGs [22] [23] [24] . These observations suggested that the mechanisms for DAA incorporation should be tolerant to modifications on the side chain of a DAA. Furthermore, DAAs have been shown to be incorporated into PGs by at least three different mechanisms, depending on the species: through the cytoplasmic steps of PG biosynthesis and via two distinct transpeptidation reactions taking place in the periplasm [24] [25] [26] [27] . Notably, two of these possible routes, namely, the cytoplasmic route for PG biosynthesis and the periplasmic route catalyzed by the essential penicillin-binding proteins, are directly linked to PG biosynthesis and are shared by virtually all PG-synthesizing bacterial species [28] [29] [30] [31] . Thus, we hypothesized that growing cells of a wide range of bacterial taxa exposed to fluorescent reporter groups attached to a DAA backbone would result in the incorporation of these florescent DAAs at sites of new PG synthesis. Indeed, a wide array of fluorophores sharing a common DAA carrier molecule proved to be readily and specifically incorporated into PGs at the sites of active growth in diverse bacterial species, Figure 1 | Modular syntheses of FDAAs. HADA 3 and NADA 5 attaching commercially available fluorophores, 7-hydroxycoumarin-3-carboxylic acid (HCC-OH; 2) and 4-chloro-7-nitrobenzofurazan (NBD-Cl; 4) to the backbone N-Boc-d-2,3-diaminopropionic acid (i.e., N-α-Boc-3-amino-d-alanine; 1); and FDL 8 and TDL 10 attaching commercially available FITC (7) and 5 (and 6-)-carboxytetramethylrhodamine succinimidyl ester (TAMRA-OSu; 9) to the backbone N-α-Boc-d-lysine 6, respectively. In our experience, HADA is the FDAA probe of choice when factors regarding ease of incorporation into the PG of diverse bacterial species, brightness, photostability and price of synthesis are considered. For example, despite its inexpensive synthesis, NADA suffers from low photostability. In contrast, although FDL and especially TDL are brighter and more photostable than HADA, the metabolic incorporation of these larger FDAAs into cell walls is particularly limited in Gram-negative bacteria. DMF, dimethylformamide; THF, tetrahydrofuran. Step 5B)
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regardless of the size of the fluorescent side chain ( Fig. 1; ref. 6 ). Although this approach addressed the inherent limitations of the methods described above, the availability of dyes of different colors also opened the way for novel applications such as virtual time-lapse microscopy, in which the dynamics of cell growth is revealed by pulse-labeling cells with different colored dyes over time. We optimized this strategy for the polarly growing, Gram-positive species Streptomyces venezuelae 6 (Fig. 2 ). An alternative to FDAAs is the use of nonfluorescent but commercially available, small and 'clickable' DAAs, which, similarly to the FDAAs, efficiently label PGs of diverse bacteria 6, 26 . Once incorporated, the reactive functional groups embedded in the DAA core structure can be selectively captured in a second step, through click chemistry, including by any fluorescent dye containing the complementary functional group 32, 33 . Although this two-step bio-orthogonal approach potentially introduces complications-such as dependence of the signal strength on the efficiency of the click chemistry reactions or nonspecific interaction of the probes with other cellular structures-this approach also substantially expands the utility of the DAA-mediated PG labeling method, as numerous clickable fluorophores with varied excitation and emission properties are available from commercial sources.
Labeling strategies and applications
FDAAs have been used to label sites of PG synthesis in a broad range of taxonomically diverse bacteria ( Table 1) . In addition, they have been used to address otherwise difficult-to-answer fundamental questions about bacterial growth and division 6, 7, 9, 10, [34] [35] [36] [37] [38] [39] . For example, FDAAs enable visualization of distinct modes of growth by resolving sites of active growth from older cell wall 6 . Distinguishing between old and new PG can be done in two distinct ways: exposing cells to FDAAs either for long durations (1-2 generations (doublings), i.e., long labeling pulses, i in Fig. 3 ) or for shorter durations (2-5% of one generation time (doubling time), i.e., short labeling pulses (ii in Fig. 3) ; this range of times was found to be optimal for the species that we studied). Although not included in this protocol, we recommend that the user determine condition-and species-specific doubling times before the short pulses. The long pulses commonly result in cells that are uniformly labeled (Fig. 4a,b) . When the excess dye is washed and the cells are allowed to grow in the absence of additional dye (i.e., a chase), the new wall synthesis commonly manifests itself as the spatiotemporal dilution of the signal. Notably, the nontoxicity of FDAAs allows this experiment to be conducted under the microscope in real time, generating single-cell time-lapse movies of cell wall growth (iii in Fig. 3; ref. 6 ). In contrast, the link of DAA incorporation to the PG biosynthetic enzymes enables FDAAs to resolve PG synthesis directly when they are added to actively growing cells for a brief labeling period. Indeed, we have observed a strong correlation between sites of FDAA labeling and previously inferred PG growth mechanisms of diverse bacterial species 6, 40 , indicating that FDAAs can be used to mark the regions of active growth. In addition, because of their DAA backbone, FDAAs can facilitate any study on the effects and mechanisms of DAA utilization, an area of active research with potential therapeutic applications 22, 23, 25, 26, 34 . They can also be used as substrate analogs to monitor the biochemical activity of essential PG synthetic enzymes (e.g., penicillin-binding proteins (PBPs)) in different species 24, 27, 41 , which previously depended on the use of radioactive substrates (including radioactive DAAs) and/or suicide probes such as fluorescent β-lactams.
Owing to its modular design, the FDAA toolkit could easily be expanded to provide probes with enhanced fluorescence properties and/or emission maxima in longer wavelength regions of the visible spectrum ( Table 2) . Indeed, the synthesis protocol for the red FDAA, TDL, contains general guidelines for researchers to synthesize their own custom fluorescent or other DAA derivatives, with different user-defined features from an appropriately functionalized DAA (e.g., amino-d-alanine or d-lysine) and any suitably activated fluorescent dye.
Combined with the universality and the specificity of these probes for live bacterial cells, this modularity facilitates other applications. For example, FDAAs can be used to distinguish actively growing bacteria in a complex environmental sample (and measure bacterial viability/activity) and to assess the diversity of growth modes of natural bacterial populations in complex microbiomes, as almost all bacteria seem to share common mechanisms for incorporating FDAAs and as their incorporation does not require special treatment of the sample. Indeed, we have shown that FDAAs can be used to reveal growth modes of bacteria in saliva and freshwater samples in situ ( Fig. 2a; ref. 6 ). Therefore, FDAAs provide a valuable alternative to cell viability procedures that measure membrane integrity, such as Life Technologies' LIVE/DEAD cell viability assays, for probing bacterial activity. In addition, current FDAAs and/or near-IR derivatives may be used to diagnose bacterial activity on surfaces or in infections, and therefore may find a wide use in fields ranging from environmental microbiology and medical bacteriology to biomaterial engineering. Access to multiple color fluorophores not only simplifies any experimental design involving other fluorescent tags (e.g., fluorescently tagged proteins), but their use in concert also enables virtual time-lapse microscopy (iv in Fig. 3 ). This application records the chronological history of PG synthesis on the cell wall itself in the form of varying colors, and it enables visualization of the location and extent of growth during the respective labeling periods on individual cells in situ (Fig. 2) . The length of the stripes from each labeling can be used to calculate the rate of a specific growth mode (e.g., tip growth or septation) for the respective labeling periods, which can only be inferred from conventional time-lapse data by complex analysis. Of pharmaceutical interest, this approach can also easily be adapted to probe effects of differing conditions (e.g., antibiotics, temperature, nutrient deprivation) on growth during specific periods at a single-cell level, facilitating the direct characterization of the effects of different antibiotics on bacterial growth and PG synthesis, as was recently demonstrated 38 . In such experiments, sequential labeling can reveal the effects of different conditions on growth. Typically, the test condition should be applied after pulse-labeling with a first color FDAA to measure the unperturbed growth pattern. Subsequent quantification of the labeling with additional colors, either during or after the treatment, will show the effect of the test condition at different times. The modularity of this labeling method can also allow modification of bacterial surfaces by a variety of other immunologically active molecules. For example, an immune response to a bacterial infection can be elicited by the synthetic DAA molecules coupled to haptens. Indeed, the proof of principle has recently been demonstrated 34 . Finally, FDAAs may provide a blueprint for new DAA-based antibiotics, as accumulating evidence suggests that a DAA core is sufficient to direct a molecule into the active sites of essential and high-value targets, PBPs, in vitro 24, 27 and in vivo 22 in diverse bacterial species.
Experimental design and crucial parameters
The synthetic routes for FDAA synthesis (Fig. 1) are simple and the labeling protocol is straightforward. HADA (3) and NADA (5) , which are currently the most robust DAA derivatives, can be prepared in good yields from N-α-Boc-protected 3-aminod-alanine (1), via nucleophilic capture of an activated ester of 7-hydroxycoumarin-3-carboxylic acid (HCC-OH; 2) or by nucleophilic aromatic substitution of 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl; 4), respectively. The d-lysine-based probes, FDL (8) and TDL (10) , are readily prepared via acylation of the ε-amino group of N-α-Boc-protected d-lysine with FITC (7) and 5-carboxytetramethylrhodamine succinimide ester (5-TAMRA-OSu; 9), respectively. Although we did not observe substantial labeling with enantiomeric fluorescent l-amino acid negative controls 6 , if necessary, these molecules can be synthesized by following the same protocols for the FDAAs using either N-α-Boc-protected 3-amino-l-alanine or N-α-Boc-protected l-lysine as the amino acid backbones. Freeze-dried FDAAs should be stored at −20 °C or below.
The probes are highly soluble in DMSO (up to 1 M). Thus, stock solutions should be made with DMSO, and these solutions should be stored in a freezer at −20 °C or below. When they are in solution, we have observed slow decomposition of NADA and FDL 6 . Therefore, lengthy storage times of the FDAA stock solutions, in particular at room temperature (24-26 °C), should be avoided. Details regarding storage, quality control and determination of photostability have been included in the Reagent Setup. For a controlled and reproducible labeling experiment, a pure and exponentially growing bacterial culture should be used, preferably started from a single colony or from a −80 °C freezer stock. In addition, the introduction of any contaminants should be avoided by using sterilized growth media and by performing experiments using sterile techniques and procedures. Although we did not observe a clear correlation between the extent of probe incorporation and the richness of the growth medium, we recommend the use of a medium (and other conditions such as temperature and aeration) that supports the optimal growth for the given species. We recommend performing labeling experiments using exponentially growing cultures. Although the duration of a labeling experiment will depend on the growth rate of the bacterium and the type of the experiment (compare the labeling durations in Table 1 ), the total time required to complete a labeling experiment from an exponentially growing culture is as little as 30 min. For example, sample processing involves ethanol fixation (10-12 min), followed by washing (three washes; 3-5 min each) and mounting of the sample(s) for imaging (~10 min). We have found that as many as four distinct labeling conditions can be sampled simultaneously without substantially extending the sample processing time. Finally, we recommend allowing at least 10 min of imaging time per sample for qualitative analyses (e.g, imaging multiple fields, 20-40 cells). If quantitative comparisons between different growth conditions are required, we recommend analyzing images of no fewer than 100 cells and performing experiments in triplicate.
Although FDAA labeling is applicable to a wide range of taxonomically diverse bacteria 6 , for initial experiments involving an untested strain (or for testing the quality of the synthesized FDAAs, see below), the user should label a strain that is known to incorporate FDAA well as a positive control. More specifically, we recommend Bacillus subtilis PY79 ATCC 55567 and E. coli MG1655 ATCC 700926 as Gram-positive and Gram-negative control strains, respectively (Fig. 4a,b) . We have found that the signal-to-noise ratio (SNR) of FDAA labeling is different for different bacterial species, with Gram-positive bacteria usually providing better SNRs (E.K., unpublished results). This observation could be attributable to the outer-membrane permeability barrier present in Gram-negative bacteria, to the fact that Gram-positive bacteria have a thicker PG layer, or to speciesspecific efficiency of FDAA incorporation or turnover.
In a given strain, although the labeling patterns are similar, if not identical (Fig. 4a,b) , and the labeling is d-isomer-specific (Fig. 4c,d ), the labeling efficiency and the SNR show a strong dependence on the nature of the probe, probe concentration, duration of incubation and medium (see Box 1). Although HADA is dimmer and less photostable than FDL or TDL, it most reproducibly and robustly labels the PG of most bacterial species, typically without the need for extensive optimization. Therefore, we recommend the use of HADA, especially for endpoint applications. Imaging of the HADA-labeled cells should be done in neutral or slightly basic buffers (e.g., 1× PBS, pH 7.4), as the deprotonation of the core fluorophore (7-hydroxycoumarin) at ~pH 7 is essential for its fluorescence. For time-course experiments, TDL is recommended over HADA, as TDL is the most photostable FDAA and its higher excitation wavelength is expected to cause the least photodamage to the cells; however, it should also be noted that TDL does not usually label Gram-negative bacteria owing to poor outer-membrane permeability (Fig. 4a) .
FDAAs are nontoxic to cells at the typical concentrations used for labeling. Indeed, growth curves of E. coli, B. subtilis and A. tumefaciens indicated that 500 µM of HADA had no effect on cell shape, lag phase, growth rate and growth yield 6 . In general, increasing the probe concentration resulted in a noticeable increase in SNR while remaining neutral to bacterial growth and morphology, at least until probe concentrations reached ~500 µM-1 mM (ref. 6) . Thus, the user should titrate the FDAA concentration until a desired SNR is achieved, while also watching for adverse effects on growth rate or morphology. We note that cells tolerate higher FDAA concentrations for short labeling times-presumably because of the shorter perturbation to the system-which can be exploited to increase the SNR on PGs labeled by relatively dimmer FDAAs such as HADA. However, longer exposure times to FDAA concentrations that are substantially higher than the optimal FDAA concentrations should be avoided, as reduced growth rates and cell shape changes might occur. In addition, the overall SNR increases as a function of incubation time, indicating that FDAA incorporation is strongly correlated with growth, but it also appears to plateau after one or two generations (1-2% of all muropeptides are labeled at the optimal probe concentration used for long pulses) 6 . Accordingly, heat-killed cells 6 or dormant cells (E.K., unpublished results) did not incorporate FDAAs. Finally, for applications that require sparse labeling, e.g., single-molecule tracking, concentrations far lower than 500 µM, e.g., ~0.1 µM for E. coli, are sufficient to decorate the cell wall with well-separated single FDAA molecules (E.K., unpublished results).
Limitations
In contrast to fluorescently modified vancomycin derivatives, which bind noncovalently to newly synthesized PGs with high affinity, our data suggest that FDAA probes are covalently incorporated into PGs via periplasmic exchange mechanisms involving bacterial transpeptidases. Procedurally, this means that the user needs to expose cells to relatively high concentrations of the probe (250 µM-1 mM). Thus, before imaging, the overwhelming signal from the excess free dye needs to be removed by washing (Fig. 4c,d) . Depending on the time required for washing, cells may continue to grow, thereby diluting the FDAA signal, especially if a growth medium is used for washes. Therefore, the user should either perform washes in buffer (e.g., cold 1× PBS) or use an appropriate fixative (such as ethanol or paraformaldehyde) before washing. Of course, washing with nontoxic buffers is essential for time-course experiments. The close correlation between known growth modes of different bacterial species with the labeling patterns of cells that are briefly pulsed with FDAAs led to the conclusion that short pulses with FDAAs mark sites of new PG synthesis 6 6, 24, 25, 27 (and E.K., unpublished data). d-Cycloserine inhibition experiments have suggested that the cytoplasmic pathway might have a role in the incorporation of some small noncanonical DAAs (including the synthetic ones with bio-orthogonal handles, e.g., alkynes or azides) in other species such as Caulobacter crescentus and Listeria monocytogenes 25, 26, 42, 43 . However, as the cytoplasmic route requires tolerance of 5-7 additional enzymatic steps in addition to the uptake of the DAAs through the inner membrane, the highly tolerable periplasmic transpeptidations for the incorporation of abnormally large and charged FDAAs appear to be a more likely route. Nonetheless, the FDAA incorporation mechanism(s) will need to be established for rigorous interpretation of the labeling data in a given species. For example, in a species that incorporates FDAAs solely through periplasmic PBPs, the short pulse data will be more indicative of the spatiotemporal distribution of the active PBPs than of the nascent PG introduction into the wall by transglycosylation of the lipid II PG precursors.
The vast majority (>90%) of the bacterial strains we have studied thus far were labeled with FDAAs on the first attempt. A few strains required optimization for significant labeling (e.g., Myxococcus xanthus) or could not be labeled (e.g., Planctomyces limnophilus). When a strain cannot be labeled, the user needs to consider several possibilities: (i) the strain might turn over FDAA-modified muropeptides effectively (e.g., high d,d-carboxypeptidase and d,d-transpeptidase activity has the potential to cleave the FDAAs of the modified muropeptides); (ii) the strain might lack a mechanism for FDAA uptake and/or incorporation; or (iii) the strain might lack a conventional DAA-rich cell wall. Although the first two possibilities could be addressed by the use of alternative metabolic labeling strategies such as fluorescent tripeptides 14 or d-Ala-d-Ala dipeptide analogs 18 , the lack of a conventional PG biosynthetic pathway in a given species might evade any of the currently available PG detection methods.
DAAs are known to modify and strengthen the PG layer 23, 25 . Although it is clear that FDAAs modify PG, it is still not known whether their incorporation under experimental concentrations affects PG properties. Nevertheless, the user is advised to determine and use the lowest probe concentration that will result in an acceptable SNR. Finally, it should be noted that the unique molecular structure of each probe presents the possibility for probe-dependent interactions with macromolecules within the
Box 1 | Evaluation of labeling
In practice, the quality of the FDAA labeling can be defined as the higher SNR of fluorescence on imaged cells compared with the untreated or with the fluorescent l-amino acid-treated controls (Fig. 4c,d) . A higher SNR not only indicates that the labeling is specific, but it also means that the contrast (or quality) of the images is higher (Fig. 4c) . Although SNR depends on a variety of instrumental factors such as optics, camera sensitivity, filters, strength of excitation light and so on, the user can increase the specific SNR on cells by following any of the following suggestions (detailed in the introduction): (i) use the brightest FDAA possible; (ii) minimize background fluorescence by thoroughly washing away any excess and unbound FDAA (Fig. 4c,d) ; (iii) use the excitation and emission filter sets that are matched to the FDAA used; and (iv) increase the strength of the excitation light or the exposure time. Because of numerous difficult-to-control experimental parameters, relating fluorescence intensity to the actual number of FDAAs on a cell is challenging. However, one can still make reliable, quantitative comparisons of labeling efficiencies between different conditions or bacterial species as long as the used FDAA and all the other sample handling and imaging conditions are identical.
cell that may result in differences in their labeling efficiencies or in labeling patterns. For example, in some bacteria, labeling with NADA required a probe concentration that was four times higher than that required for the HADA probe in order to achieve a similar SNR (E.K., unpublished results). In addition, the size of the probe can affect its efficient uptake and incorporation. Indeed, although the patterns of labeling with HADA, NADA and TDL were similar within E. coli or B. subtilis (Fig. 4a,b) , TDL does not strongly label E. coli 6 (Fig. 4a) unless outer-membrane permeability is increased (E.K., unpublished data). The buffer is stable at room temperature for at least 1 year. Acidic, basic or strong redox buffers should be avoided, as they can modify dye molecules irreversibly.
MaterIals

REAGENTS
• Many types of bacteria can form colonies on solid nutrient agar plates, which can be used as a short-term (1-2 weeks) strain storage method. Premade LB agar plates are commercially available. Single colonies can be obtained by the streaking technique after some cells are transferred as a small spot on the plate using a sterile inoculation loop. The large concentration of cells on this spot can be diluted by dragging a new sterile loop from this spot and by zig-zagging until ~25% of the plate's surface is covered. To get well-isolated, single colony-forming units, this should be repeated three more times, each time with new sterile loops by dragging from the previous section and covering the next untouched ~25% of the plate's surface. Once the streaking is done, the plates should be incubated lids down under optimal growth conditions until visible colonies form. For example, E. coli can form visible colonies on LB agar within 10-12 h if it is incubated at 37 °C. For other species that may require more specialized growth media and conditions, follow the instructions available at http://www.atcc.org/. Tracking bacterial growth The labeling experiments should be performed with exponentially growing bacteria to get optimal labeling results. The exponential phase (or the log phase) follows the lag phase and precedes the stationary phase, and it is defined as the period in which the net increase in the number of bacterial cells per unit time is proportional to the current number of cells. Generally, the OD of liquid bacterial cultures is proportional to the concentration of bacterial cells. Thus, by following the increase of the OD over time, one can determine whether a culture is in the exponential phase. The OD of a culture can be quantified by measuring OD at 600 nm (OD 600 ) using a spectrophotometer, and by following the manufacturer's instructions. Alternatively, one can estimate OD of a culture by comparing it to commercially available McFarland standards (roughly, the McFarland standards numbers 1, 2, 3 and 4 correspond to OD 600 values of 0.25, 0.4, 0.6 and 0.7). More specialized methods may be required for other species, such as obligate intracellular bacteria. Making a freezer stock of bacteria In a sterile, cryogenic, 2-ml vial, combine 900 µl of pure liquid cultures from late exponential phase with 100 µl of sterile DMSO or with 100 µl of sterile glycerol, and mix well. Without delay, transfer the tube to a freezer at −80 °C. To start a new culture, working aseptically, transfer a small volume (~1 µl) of the frozen stock into 2-3 ml of sterile liquid medium.
Stock solution of FDAAs
The FDAA salts prepared as described in Step 1 of the PROCEDURE are poorly soluble in water. For example, at room temperature, the water solubility (S W ) of HADA is ~3 mM. Thus, stock solutions should be made in DMSO (referred to as FDAA DMSO throughout). Use the following formula to determine the right volume of DMSO in which to dissolve your preweighed FDAA.
where V = volume of DMSO to be added in µl; W = mass of the FDAA aliquot in mg; M = molecular mass of the FDAA salt ( Table 2 ) in g mol −1 ; C = desired concentration of the stock solution in mM.
The concentration of the stock solution should be determined on the basis of the desired final DMSO concentration in the culture (usually between 0.1-1%). For example, for final concentrations of 1 mM FDAA and 1% (vol/vol) DMSO, prepare a 100 mM (100×) FDAA stock solution. All of the FDAAs are soluble in DMSO at least up to 1 M concentrations. Sterilization of stock solutions is not required, but it could be necessary for applications that require extended labeling times (>1 d). When required, the stock solutions should be filter-sterilized using 0.2-µm-pore DMSO-resilient nylon filters. Chemical stability of FDAA stock solutions Powdered FDAAs (in dry compartments) and stock solutions should be stored at −20 °C or lower. The stock solutions should be thawed rapidly by bringing the frozen stock to room temperature. In general, excessive thawing and refreezing, or extended exposure and storage at room temperature, should be avoided. Therefore, it is recommended to divide a fresh stock solution into smaller multiple-use aliquots. We have not observed decomposition of powder FDAAs over several months when they are kept dry and at −20 °C or lower. Similarly, in our hands the potency of stock solutions remained unchanged when they were frozen and thawed approximately ten times; however, we detected marked decomposition of the material when stock solutions were kept at room temperature for 30 d in the dark (E.K., unpublished results). Quality control The effective concentration of an FDAA in a stock solution can be determined in three ways: first, the stock solution can be analyzed by HPLC and the HPLC profile of the current stock solution can be compared with that of the original stock solution. This will give both the effective FDAA concentration and the distribution of any decomposition products. Preparative HPLC can be used to re-purify FDAA recovered from an old stock solution. Second, a standard curve of concentration versus absorbance can be made from a fresh stock solution and then be used to estimate the effective FDAA concentration of an unknown stock solution. For example, HADA has a strong linear correlation of concentration and absorbance (at 400 nm) between 1-50 µM concentrations in 1× PBS (pH 7.4) and 1% (vol/vol) DMSO. Finally, one can compare the cell signal obtained with an old stock solution in parallel with a freshly prepared one, in a microscopy experiment on a model bacterium (e.g., B. subtilis). The old stock should be discarded or the FDAA should be re-purified, if any decrease of signal or changes in labeling patterns is noted. Photostability Despite the photolability of the smaller FDAAs (NADA, and to a lesser extent, HADA) during fluorescence microscopy applications, ambient light in a typical laboratory does not noticeably affect the brightness of labeled samples. Still, avoiding prolonged exposure of the samples to incident light is recommended. For experimental purposes, the photostability of an FDAA can be estimated by repeatedly exposing a field of labeled cells with typical microscopy and image acquisition setups. Cells that are labeled with a photosensitive FDAA (e.g., NADA) will exhibit a reduction of fluorescence signal with each exposure. The rate of photobleaching can be determined by calculating the percentage of fluorescence decrease on a cell over repeated exposures. Among the four FDAAs reported here, TDL is the photophysically most impressive FDAA. It is bright, extremely photostable and its red-shifted excitation helps reduce photodamage to the cells during time-lapse microscopy.
Although FDL and NADA are seemingly brighter than TDL, they are also prone to extensive photobleaching. HADA is moderately bright, but it is much more photostable than NADA. If constant exposure of a single cell is required (e.g., time-lapse or structured illumination microscopy), then the use of TDL is recommended (followed by HADA, FDL and NADA). The choice of FDAA is more forgiving for endpoint experiments (e.g., short pulses or virtual time-lapse experiments). Fixation To quench labeling reactions, we recommend the generic 70% (vol/vol) ethanol or paraformaldehyde fixation techniques. Given its convenience and its chemical inertness toward the PG cell wall, ethanol fixation can be followed as the starting point. One should note that ethanol fixation causes an apparent loss of the cell pellet once the fixed cells are rehydrated in an aqueous solution (e.g., 1× PBS). Furthermore, in some Gram-positive species such as B. subtilis, ethanol fixation results in partly phase-transparent (i.e., hollow) cells, which does not seem to affect the cell wall structure. In S. pneumoniae, ethanol fixation causes complete autolysis of the cells upon rehydration, which can partly be overcome by heat-killing the cells before the ethanol fixation. Glutaraldehyde fixation should be avoided, as it causes high background signal, presumably via nonspecific cross-linking of free FDAAs.
EQUIPMENT SETUP HPLC FDAAs are purified by HPLC. The HPLC instrument should be set up according to the manufacturer's recommendations and specifications. Mass spectrometry analysis Mass spectral data are recorded. The following instruments have been used in our laboratory: Waters LCT Classic electrospray time-of-flight analyzer with an Agilent capillary HPLC inlet; Sciex API III electrospray quadrupole with a direct infusion inlet; or Finnigan MAT-95. Sample ionization is achieved through the use of chemical ionization (CI) or electron impact (EI). Vacuum pump aspirator Although excess FDAAs can be removed by pipetting the supernatant of pelleted cells (1 min, maximum speed in a microcentrifuge, room temperature), we recommend removing the supernatant using a vacuum pump aspirator, as the labeling protocols involve several washes. In our hands, aspirating supernatants of multiple samples with the same pipette tip significantly reduces the dead-time between washes and does not cause a noticeable cross-contamination. Wide-field fluorescence microscope HADA can be imaged in the DAPI channel, NADA and FDL can be imaged in the FITC channel, and TDL can be imaged in the TAMRA channel on a conventional wide-field fluorescence microscope. See also Table 2. proceDure  crItIcal With FDAAs in hand, start at Step 2 of the PROCEDURE.
synthesis of FDaas 1|
To prepare the FDAAs used in these studies (HADA, NADA, FDL and/or TDL), follow the procedures described in options A-D, respectively. Option D can also be used for the custom synthesis of novel FDAAs. One can follow these steps and simply change which commercially available succinimidyl ester activated fluorophore and/or which Boc-protected d-diamino acid linker is used in Step 1D(ii) as long as the molar ratios are kept constant. The HPLC profile in Step 1D(xi) will change depending on the product. The powder will be the HCl salt of NADA.  crItIcal step The TFA salt of the product is not stable. It must be converted to and stored as the HCl salt.  pause poInt Store the product at −20 °C. In our hands, no decomposition was detected in at least 6 months. (c) synthesis of FDl • tIMInG ~34 h (i) Flame-dry a 10-ml round-bottomed flask containing a magnetic stir bar and fill it with argon, as described in
Step 1A(i-vi). 4| Prepare desired stock solution(s) of FDAA in DMSO, as described in Reagent Setup.  crItIcal step DMSO stock solutions of FDAAs should be stored at −20 °C or at lower temperatures, as they have been observed to decay at prolonged exposure to room temperature. The stocks can be kept frozen at −20 °C for many months and thawed at least 10-15 times without decomposing.
labeling with FDaas 5| If the species under investigation has not been stained by FDAA before, follow the steps in option A using HADA as the FDAA. Options B-F are labeling procedures for specific applications. Long pulses for endpoint or time-lapse microscopy experiments are performed as described in option B using any FDAA at its optimal concentration (table 2, ref. 6, or as determined by performing Step 5A). To simplify the procedure, we have used the conditions optimized for E. coli as an example. For option C, we define short-pulse labeling as the growth of cells in the presence of FDAAs for durations that lie between 2-8% of the doubling time (ii in Fig. 3) . In short pulses, higher FDAA and DMSO concentrations can be used without any signs of growth defects, because the cells are exposed for less time; for a higher SNR during microscopy, we recommend FDAA concentrations at least two times higher than those determined in Step 5A or used in
Step 5B.
Short pulses can also be performed on about ten times more concentrated cells without causing a noticeable change in labeling patterns (option D), substantially reducing the amount of FDAA required per experiment. Reduction in sample volume also makes handling of multiple samples easier. Larger numbers of conditions (e.g., different FDAAs) can be sampled at the same time using, for example, multiple wells of a 48-well plate and a plate incubator.
For option E, we define a virtual time-lapse microscopy experiment as the consecutive exposure of the cells to differently colored FDAAs (iv in Fig. 3 ) in a series of short pulses. This can be used either to probe growth dynamics or as a diagnostic tool to probe the effects of different conditions (e.g., antibiotics and temperature) during the respective labeling periods on growth. Washing cells before, between and after each pulse with prewarmed medium normalizes the effect of the multiple pulses and minimizes bleed-over of the signals caused by the incorporation from the excess FDAA left from the previous round.
Step 5E was optimized for S. venezuelae 6 ; the labeling duration and the starting OD should be adjusted for different growth rates so that the cells are kept in the exponential phase throughout a given labeling period.
Option F describes how to use FDAAs to probe active bacteria in a saliva sample, and it could be adapted for the analysis of other environmental samples. ? trouBlesHootInG (v) Incubate the culture in the desired conditions (e.g., in species-specific rich medium at optimal growth temperature).
Monitor the effects of different HADA and DMSO (final 1%) concentrations on growth and morphology by measuring OD 600 and checking cell morphology under light microscopy after each doubling. Step 5C, short pulse for detecting the site of active growth: 30 min
Step 5D, 'FDAA-saver' short pulse for detecting the site of active growth: 40 min step 5e, virtual time-lapse using short pulses of multiple FDaas i-iv: 10 min vi-vii: 10 min viii-x: 10 min xi-xv: 10 min xvi: 20 min
Step 5F, labeling environmental samples: 30 min-4 h
Step 6, washing and resuspending cells, 10 min
Step 7A, preparation of imaging agar pads: 10 min
Step 7B, preparation of nutrient agar pads for time-lapse microscopy of live cells prepared in
Step 5B: 10 min Steps 8-10, imaging and evaluation, 1 h 30 min
